What EMA Aesthetics does

EMA Aesthetics Limited is a Dublin-headquartered, privately-held medical aesthetics company founded in 2019 that develops, manufactures, and distributes professional-grade facial treatment devices and proprietary cosmeceutical consumables to clinics, medspas, and aesthetic practitioners globally. Its core platform is the Préime DermaFacial, an IoT-enabled combination therapy device integrating five treatment modalities, paired with the exclusive Préime DermaCeuticals consumables line including bespoke formulations such as TXA Bright, Glutathione, and Ascorbic Acid 20. The company also sells the HydraCool Plus aesthetic facial device bundled with SRS cosmeceuticals, and in March 2026 unveiled BLŪPRIN™, a regenerative aesthetics platform built on human exosomes derived from umbilical cord blood plasma in collaboration with MonoTx Global Holdings.

The business model combines hardware sales (devices sold to clinics), recurring consumables revenue (branded cosmeceuticals that must be used with the proprietary devices), and licensing/royalty streams via an exclusive worldwide distribution agreement signed with Sinclair Pharma in 2022 covering all territories outside the UK and Germany, where Sinclair's Cocoon/EDB subsidiary accelerates commercialization. EMA operates regional offices in Belgium, Singapore, and the United Arab Emirates alongside its Dublin headquarters, and reports a partner network spanning 55+ countries. Go-to-market relies on a multi-tier B2B model: direct enterprise sales and demo requests through the website, combined with channel partners/distributors who place devices and consumables into aesthetic clinics, supplemented by industry event presence (notably AMWC Monaco for product launches) and content marketing via blog, Instagram, Facebook, and LinkedIn. Pricing is quote-based with multi-year partnership contracts rather than published list pricing. The company is founder-led (Malcolm Wall Morris, CEO) with executive leadership including a Chairman, COO, and CFO; total disclosed equity funding is approximately $6.1M across three rounds in 2019–2021.

Name

EMA Aesthetics

Legal name

EMA Aesthetics Limited

Website

https://emaaesthetics.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

EMA Aesthetics Limited is a Dublin-based, privately-held medical aesthetics company founded in 2019 that designs and distributes proprietary IoT-enabled facial treatment devices (Préime DermaFacial, HydraCool Plus), exclusive cosmeceutical consumables, and the BLŪPRIN regenerative exosome platform to clinics, medspas, and aesthetic practitioners across 55+ countries, primarily via an exclusive distribution agreement with Sinclair Pharma.

Ownership category

akta.pro rank

Product category

Medical Aesthetic Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning) (CRABAKAI)

akta.pro secondary industries

Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Professional/Backbar Skincare (Esthetician & Spa Use) (CRABAAAK)

Keywords

• Medical aesthetic devices
• Professional cosmeceuticals
• Aesthetic facial equipment
• Professional skincare technology
• Regenerative aesthetics

Headquarters

HQ city

Dublin

HQ country

Ireland

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Marketing or Sales, Personnel, Operations

Revenue model

1. Aesthetic Facial Device Sales: Sale of proprietary aesthetic facial devices including Préime DermaFacial and HydraCool Plus. Devices are sold through direct partnerships and distribution agreements with Sinclair Pharma for global markets outside UK/Germany.
2. Consumables and DermaCeuticals: Sale of exclusive Préime consumables and cosmeceutical products (DermaCeuticals, SRS cosmeceuticals) for use with proprietary devices. Includes professional solutions like TXA Bright, Glutathione, and Ascorbic Acid formulations.
3. Licensing and Distribution Rights: Revenue from licensing proprietary technology (Préime DermaFacial) to distribution partners. Exclusive product license agreements with partners like Sinclair Pharma for worldwide distribution.
4. Regenerative Aesthetics Solutions: Future commercialization of advanced regenerative solutions through MonoTx collaboration, including BLUPRIN exosome platform for professional aesthetics.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

EMA Aesthetics designs, manufactures, and distributes professional aesthetic facial devices and proprietary cosmeceutical consumables for medical aesthetic clinics and medspas. Its flagship Préime DermaFacial device combines five technologies in IoT-enabled combination therapy using exclusive branded consumables, complemented by the HydraCool Plus device with SRS cosmeceuticals and the BLŪPRIN™ human exosome platform for regenerative aesthetics. The company sells through a global B2B partner and distribution network spanning 30–55 countries.

Product overview

EMA Aesthetics offers a portfolio of aesthetic facial devices and professional skincare products. The core product line includes the Préime DermaFacial (an IoT-powered multi-technology facial device) combined with Préime DermaCeuticals consumables, and the HydraCool Plus device paired with SRS cosmeceuticals. The company also offers the BLŪPRIN™ human exosome platform for regenerative aesthetics. Products target professional aesthetic clinics, medspas, and skincare practitioners globally through a partnership/distribution model.

Differentiator

Problem solved

Functional benefit

Brands

• Préime DermaFacial: The world's most advanced aesthetic facial device, offering five powerful technologies in combination therapy for personalised facial treatments. Powered by IoT (Internet of Things) technology. Designed and manufactured in Europe.
• Préime DermaCeuticals
• HydraCool Plus
• SRS Cosmeceuticals
• Préime DermaProfessional
• BLŪPRIN™

Products and services

• Pr\u00e9ime DermaFacial Professional aesthetic facial device that combines five technologies in a single IoT-enabled combination-therapy platform, used with exclusive Pr\u00e9ime consumables to enable personalised facial treatments for medical aesthetic clinics and medspas.
• Pr\u00e9ime DermaCeuticals Proprietary line of bespoke skincare cocktails and advanced components designed to be combined with and delivered by the Pr\u00e9ime DermaFacial device for professional aesthetic treatments.
• HydraCool Plus Professional aesthetic facial device combined with SRS cosmeceuticals to deliver skin, body, and scalp care treatments for medical aesthetic providers and medspas.
• SRS Cosmeceuticals Professional-grade skincare line including SRS Skin Protect SPF 50+, TXA Bright (tranexamic acid-based brightening solution), Glutathione, and Ascorbic Acid 20 advanced components, designed for use with the HydraCool Plus aesthetic facial device.
• Pr\u00e9ime DermaProfessional Carefully sourced natural ingredients focused on restoration and regeneration, used in conjunction with the Pr\u00e9ime platform for professional aesthetic treatments.
• BL\u016aPRIN\u2122 Human exosome platform derived from human umbilical cord blood plasma, positioned as a next-generation regenerative aesthetics offering for advanced skin rejuvenation in medical aesthetic clinics and medspas.

Quantifiable outcome

• Plastics neutral across entire brand portfolio
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature6 records

Partnerships

Three partnerships are on record, tiered core and flagship.

• MonoTx Global Holdings, Inc.coreStrategic or Co-development Partner · 13 March 2026EMA Aesthetics made a strategic investment in MonoTx, a U.S.-based clinical-stage biotech focused on regenerative materials derived from umbilical cord blood. As part of the transaction, EMA Aesthetics will appoint one director to MonoTx's Board of Directors for governance participation and strategic alignment. The collaboration aims to support joint product development, clinical validation, and future commercialization of advanced regenerative solutions across professional aesthetics and adjacent categories. BLUPRIN exosome platform is a key product from this collaboration.
• 4oceancoreOthers · 24 September 2022EMA Aesthetics signed agreement with 4ocean's Certified Cleanup Partnership Program to become plastics neutral across its entire brand portfolio. EMA became 4ocean's first partner from the aesthetics industry. The agreement provides 4ocean with sufficient resources to remove 4x EMA's current plastic footprint from the world's oceans (5,000 lbs commitment).
• Sinclair Pharma LimitedflagshipChannel Partner/ Reseller/ Distributor · 1 March 2022Exclusive product license and worldwide distribution agreement for Préime DermaFacial with Sinclair Pharma for all territories outside the UK and Germany. Sinclair EDB division subsidiary Cocoon is perfectly placed to accelerate global commercialization of the world's most advanced aesthetic facial device. Sinclair has direct presence in key markets and extensive distribution channels.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Beauty Health Company (HydraFacial): Markets the HydraFacial hydradermabrasion system, the closest direct competitor to Préime DermaFacial. Both sell IoT/networked multi-technology facial devices to medspas and clinics supported by proprietary consumables, generating recurring revenue from installed bases.
• Venus Concept: Develops and commercializes energy-based aesthetic devices (e.g., Venus Versa, Venus Viva) sold through a similar subscription/consumables model to clinics and medspas. Comparable scale, distribution model, and target customer to EMA's aesthetic device business.

Broad incumbents

• Cynosure: Established aesthetic device manufacturer offering a broad portfolio including PicoSure, Potenza, and TempSure. Competes with EMA in the multi-technology aesthetic facial category but operates at significantly larger scale with deeper R&D.
• Cutera: Public aesthetic device company offering laser, RF, and body-contouring systems (e.g., AviClear, Secret RF, truSculpt) to medical aesthetic practices. Overlapping product categories with EMA but with a much larger installed base and direct US sales force.
• InMode: Aesthetic medical device company with platforms spanning body contouring, skin remodeling, and hair removal. Sells into the same medical aesthetic and medspa channels as EMA via a mix of direct sales and distributors.
• Alma Lasers: Global aesthetic and medical laser company offering multi-technology platforms (Accent, Harmony, Soprano). Competes in the same clinic-channel with combination-therapy devices, though at meaningfully larger scale and broader category coverage.
• Solta Medical (Bausch Health): Aesthetic device brand owned by Bausch Health, including Thermage, Fraxel, and Clear+Brilliant. Comparable in targeting dermatology and medspa channels with energy-based facial platforms, supported by a much larger corporate parent.
• Merz Aesthetics: Global aesthetics business within Merz Group offering injectables (Belotero, Radiesse), devices, and professional skincare. Overlaps with EMA in the professional skincare and aesthetic treatment ecosystem serving clinics and practitioners.
• Galderma: Dermatology-focused aesthetics company with injectable, skincare, and therapeutic lines. Targets the same dermatologist and aesthetic clinic channel as EMA, with overlapping regenerative and skin-quality themes relevant to BLŪPRIN's category.

Others

• Sinclair Pharma: EMA's exclusive global distribution partner for Préime DermaFacial. Operates a portfolio of aesthetic brands including Ellansé and MaiLi; comparable in channel and end-customer but structurally a partner and channel rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/EMAaestheticsGlobal
• LinkedInie.linkedin.com/company/emaaestheticsglobal
• Instagraminstagram.com/emaaestheticsglobal

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EMA Aesthetics